Natoli installed a NP-RD30 rotary tablet press for R&D at its new lab in Germany.
Natoli Engineering installed its Natoli NP-RD30 rotary tablet press in its new research and training facility, the Diosna ProcessLab in Osnabrück, Germany. The lab was completed in April 2020 and is built for research and formulation trials as well as virtual and in-person training classes. With the tablet press, the lab offers complete production of tablets from powder mixing, granulation, final blending, and tableting to coating.
The tablet press combines the design of a full-scale production press with the analytical capabilities of an R&D machine. Designed to tackle formulation and scale-up challenges, the tablet press comes equipped with a 21” HMI touchscreen, a USB port for data transfer, rolling casters, a dual vacuum system, a built-in calibration tool, upper and lower punch seals, powder recirculation system, and a self-adjusting lower punch with a push button feature, a Sept. 9, 2020 company press release said. The fast-fill cam design produces a vacuum to help with die filling for tablet weights while featuring diameter pre- and main compression rollers, independent overload, ejection, and take-off force monitoring.
Source: Natoli
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.